2023 Q4 Form 10-K Financial Statement
#000147793223007307 Filed on October 03, 2023
Income Statement
Concept | 2023 Q4 | 2023 Q2 | 2023 |
---|---|---|---|
Revenue | $21.83M | $17.81M | $80.68M |
YoY Change | -19.42% | 17.17% | 80.95% |
Cost Of Revenue | $13.56M | $10.21M | $47.12M |
YoY Change | -19.16% | 24.66% | 142.93% |
Gross Profit | $8.271M | $7.600M | $33.56M |
YoY Change | -19.77% | 8.42% | 33.23% |
Gross Profit Margin | 37.89% | 42.67% | 41.6% |
Selling, General & Admin | $4.995M | $6.690M | $19.92M |
YoY Change | -55.6% | -24.83% | -8.51% |
% of Gross Profit | 60.38% | 88.03% | 59.37% |
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $328.6K | $950.0K | $944.7K |
YoY Change | -72.62% | -24.0% | 64.49% |
% of Gross Profit | 3.97% | 12.5% | 2.82% |
Operating Expenses | $10.06M | $7.650M | $41.11M |
YoY Change | -19.21% | -24.63% | 47.66% |
Operating Profit | -$1.787M | -$50.00K | -$7.552M |
YoY Change | -16.49% | -98.41% | 184.73% |
Interest Expense | -$1.077M | -$2.380M | -$4.760M |
YoY Change | -39.83% | 1387.5% | -12531.44% |
% of Operating Profit | |||
Other Income/Expense, Net | -$1.077M | -$10.92M | |
YoY Change | -39.92% | 12322.34% | |
Pretax Income | -$2.864M | -$16.14M | -$18.47M |
YoY Change | -178.9% | 389.09% | 620.3% |
Income Tax | $694.8K | -$2.600M | $3.049M |
% Of Pretax Income | |||
Net Earnings | -$2.438M | -$15.36M | -$17.49M |
YoY Change | -194.34% | 486.26% | 754.84% |
Net Earnings / Revenue | -11.17% | -86.24% | -21.68% |
Basic Earnings Per Share | -$0.12 | -$0.96 | |
Diluted Earnings Per Share | -$0.12 | -$0.79 | -$0.96 |
COMMON SHARES | |||
Basic Shares Outstanding | 20.40M shares | 18.09M shares | 17.88M shares |
Diluted Shares Outstanding | 17.88M shares |
Balance Sheet
Concept | 2023 Q4 | 2023 Q2 | 2023 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $1.844M | $4.490M | $4.490M |
YoY Change | -59.1% | -37.2% | -37.2% |
Cash & Equivalents | $1.844M | $4.492M | |
Short-Term Investments | |||
Other Short-Term Assets | $697.6K | $1.250M | $1.250M |
YoY Change | -64.04% | -83.87% | -83.87% |
Inventory | $14.66M | $11.56M | $11.56M |
Prepaid Expenses | |||
Receivables | $5.377M | $7.164M | $7.160M |
Other Receivables | $0.00 | $990.0K | $990.0K |
Total Short-Term Assets | $22.58M | $25.46M | $25.46M |
YoY Change | 2.09% | 49.2% | 22.64% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $7.600M | $7.526M | $7.940M |
YoY Change | -3.06% | -6.46% | -3.99% |
Goodwill | $11.81M | $10.25M | |
YoY Change | 23.49% | ||
Intangibles | $11.30M | $13.57M | |
YoY Change | 12.61% | ||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $441.8K | $96.73K | $6.640M |
YoY Change | -82.6% | -3.63% | 216.19% |
Total Long-Term Assets | $39.58M | $38.40M | $38.39M |
YoY Change | -27.41% | 22.17% | 42.66% |
TOTAL ASSETS | |||
Total Short-Term Assets | $22.58M | $25.46M | $25.46M |
Total Long-Term Assets | $39.58M | $38.40M | $38.39M |
Total Assets | $62.16M | $63.85M | $63.85M |
YoY Change | -18.89% | 31.68% | 33.94% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $3.018M | $3.970M | $3.970M |
YoY Change | -27.46% | 53.2% | 96.53% |
Accrued Expenses | $2.658M | $3.366M | $4.320M |
YoY Change | -44.62% | 253.43% | 158.68% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $4.167M | $880.0K | $880.0K |
YoY Change | |||
Long-Term Debt Due | $12.69M | $9.640M | $9.640M |
YoY Change | 498.56% | 77.86% | 77.86% |
Total Short-Term Liabilities | $24.26M | $19.61M | $19.61M |
YoY Change | 60.74% | 93.59% | 110.86% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $11.28M | $16.25M | $16.25M |
YoY Change | -53.81% | 83.0% | 83.0% |
Other Long-Term Liabilities | $1.163M | $160.0K | $160.0K |
YoY Change | 205.97% | -76.49% | -77.14% |
Total Long-Term Liabilities | $12.44M | $16.41M | $16.41M |
YoY Change | -49.83% | 71.36% | 71.29% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $24.26M | $19.61M | $19.61M |
Total Long-Term Liabilities | $12.44M | $16.41M | $16.41M |
Total Liabilities | $36.70M | $36.02M | $35.51M |
YoY Change | -7.58% | 82.78% | 87.59% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$27.00M | -$23.20M | |
YoY Change | 269.98% | ||
Common Stock | $20.31K | $20.22K | |
YoY Change | 20.96% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $25.46M | $27.84M | $28.34M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $62.16M | $63.85M | $63.85M |
YoY Change | -18.89% | 31.68% | 33.94% |
Cashflow Statement
Concept | 2023 Q4 | 2023 Q2 | 2023 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$2.438M | -$15.36M | -$17.49M |
YoY Change | -194.34% | 486.26% | 754.84% |
Depreciation, Depletion And Amortization | $328.6K | $950.0K | $944.7K |
YoY Change | -72.62% | -24.0% | 64.49% |
Cash From Operating Activities | $220.00 | -$3.320M | $202.7K |
YoY Change | -100.0% | 101.21% | -61.16% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $254.1K | $660.0K | $937.6K |
YoY Change | 747.17% | 32.0% | -84.77% |
Acquisitions | -$500.0K | ||
YoY Change | -80.58% | ||
Other Investing Activities | $0.00 | $730.0K | -$1.640M |
YoY Change | -100.0% | -170.87% | -69.91% |
Cash From Investing Activities | -$254.1K | $80.00K | -$2.575M |
YoY Change | -104.32% | -105.19% | -77.81% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 1.681M | 6.550M | -$285.3K |
YoY Change | -115.61% | 12.35% | -107.71% |
NET CHANGE | |||
Cash From Operating Activities | 220.0 | -3.320M | $202.7K |
Cash From Investing Activities | -254.1K | 80.00K | -$2.575M |
Cash From Financing Activities | 1.681M | 6.550M | -$285.3K |
Net Change In Cash | 1.427M | 3.310M | -$2.342M |
YoY Change | 17.96% | 25.38% | -68.28% |
FREE CASH FLOW | |||
Cash From Operating Activities | $220.00 | -$3.320M | $202.7K |
Capital Expenditures | $254.1K | $660.0K | $937.6K |
Free Cash Flow | -$253.9K | -$3.980M | -$734.9K |
YoY Change | -104.18% | 85.12% | -86.95% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001775194 | |
CY2023 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--06-30 | |
CY2023 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2023 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
100000000 | shares |
CY2023Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
500000 | shares |
CY2023Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
500000 | shares |
CY2023Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
20215961 | shares |
CY2022Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
16713345 | shares |
CY2022 | upxi |
Stock Issued During Period Value Acquisitions Amount
StockIssuedDuringPeriodValueAcquisitionsAmount
|
0 | usd |
CY2023Q1 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
8500000 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
|
0 | usd |
CY2023 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
|
P29M | |
CY2022 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
568031 | usd |
CY2022 | upxi |
Additional Lease Expense
AdditionalLeaseExpense
|
117992 | usd |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
0 | usd | |
CY2023 | upxi |
Amortization Of Intangibles Assets
AmortizationOfIntangiblesAssets
|
17148701 | usd |
CY2022Q2 | us-gaap |
Short Term Debt Interest Rate Increase
ShortTermDebtInterestRateIncrease
|
0.085 | pure |
CY2023 | dei |
Document Type
DocumentType
|
10-K | |
CY2023 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2023 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-06-30 | |
CY2023 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023 | dei |
Entity File Number
EntityFileNumber
|
333-255266 | |
CY2023 | dei |
Entity Registrant Name
EntityRegistrantName
|
UPEXI, INC. | |
CY2023 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | |
CY2023 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
83-3378978 | |
CY2023 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
3030 North Rocky Point Drive | |
CY2023 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Tampa | |
CY2023 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
FL | |
CY2023 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
33607 | |
CY2023 | dei |
City Area Code
CityAreaCode
|
701 | |
CY2023 | dei |
Local Phone Number
LocalPhoneNumber
|
353-5425 | |
CY2023 | dei |
Security12b Title
Security12bTitle
|
Common Stock, par value $0.001 | |
CY2023 | dei |
Trading Symbol
TradingSymbol
|
UPXI | |
CY2023 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
CY2023 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2023 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2023 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2023 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
true | |
CY2023 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2022Q4 | dei |
Entity Public Float
EntityPublicFloat
|
38240085 | usd |
CY2023Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
20397779 | shares |
CY2023 | dei |
Auditor Name
AuditorName
|
B F Borgers CPA PC | |
CY2023 | dei |
Auditor Location
AuditorLocation
|
Lakewood, Colorado | |
CY2023 | dei |
Auditor Firm
AuditorFirmId
|
5041 | |
CY2023Q2 | us-gaap |
Cash
Cash
|
4492291 | usd |
CY2022Q2 | us-gaap |
Cash
Cash
|
7149806 | usd |
CY2023Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
7163564 | usd |
CY2022Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
939875 | usd |
CY2023Q2 | us-gaap |
Inventory Net
InventoryNet
|
11557128 | usd |
CY2022Q2 | us-gaap |
Inventory Net
InventoryNet
|
4725685 | usd |
CY2023Q2 | upxi |
Due From Bloomios
DueFromBloomios
|
845443 | usd |
CY2022Q2 | upxi |
Due From Bloomios
DueFromBloomios
|
0 | usd |
CY2023Q2 | upxi |
Deferred Tax Asset Current
DeferredTaxAssetCurrent
|
0 | usd |
CY2022Q2 | upxi |
Deferred Tax Asset Current
DeferredTaxAssetCurrent
|
462070 | usd |
CY2023Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1307299 | usd |
CY2022Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
760900 | usd |
CY2023Q2 | us-gaap |
Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
89989 | usd |
CY2022Q2 | us-gaap |
Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
3023286 | usd |
CY2023Q2 | us-gaap |
Assets Current
AssetsCurrent
|
25455714 | usd |
CY2022Q2 | us-gaap |
Assets Current
AssetsCurrent
|
17061622 | usd |
CY2023Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
7526463 | usd |
CY2022Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
7338866 | usd |
CY2023Q2 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
13571960 | usd |
CY2022Q2 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
8755012 | usd |
CY2023Q2 | us-gaap |
Goodwill
Goodwill
|
10251281 | usd |
CY2022Q2 | us-gaap |
Goodwill
Goodwill
|
4644609 | usd |
CY2023Q2 | upxi |
Deferred Tax Asset Non Current
DeferredTaxAssetNonCurrent
|
5604056 | usd |
CY2022Q2 | upxi |
Deferred Tax Asset Non Current
DeferredTaxAssetNonCurrent
|
2002759 | usd |
CY2023Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
96728 | usd |
CY2022Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
75613 | usd |
CY2023Q2 | upxi |
Assets Held For Sale
AssetsHeldForSale
|
936054 | usd |
CY2022Q2 | upxi |
Assets Held For Sale
AssetsHeldForSale
|
7767698 | usd |
CY2023Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
410811 | usd |
CY2022Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
844856 | usd |
CY2023Q2 | us-gaap |
Other Assets
OtherAssets
|
38397353 | usd |
CY2022Q2 | us-gaap |
Other Assets
OtherAssets
|
31429413 | usd |
CY2023Q2 | us-gaap |
Assets
Assets
|
63853067 | usd |
CY2022Q2 | us-gaap |
Assets
Assets
|
48491035 | usd |
CY2023Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3969746 | usd |
CY2022Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1572275 | usd |
CY2023Q2 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
533842 | usd |
CY2022Q2 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
489712 | usd |
CY2023Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3365562 | usd |
CY2022Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
816632 | usd |
CY2023Q2 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
2731377 | usd |
CY2022Q2 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
749752 | usd |
CY2023Q2 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
1254167 | usd |
CY2022Q2 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
3125000 | usd |
CY2023Q2 | upxi |
Current Portion Of Acquisition Note Payable
CurrentPortionOfAcquisitionNotePayable
|
5656620 | usd |
CY2022Q2 | upxi |
Current Portion Of Acquisition Note Payable
CurrentPortionOfAcquisitionNotePayable
|
1550000 | usd |
CY2023Q2 | us-gaap |
Line Of Credit
LineOfCredit
|
882845 | usd |
CY2022Q2 | us-gaap |
Line Of Credit
LineOfCredit
|
0 | usd |
CY2023Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
419443 | usd |
CY2022Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
183881 | usd |
CY2023Q2 | upxi |
Current Liabilities Of Discontinued Operations
CurrentLiabilitiesOfDiscontinuedOperations
|
792408 | usd |
CY2022Q2 | upxi |
Current Liabilities Of Discontinued Operations
CurrentLiabilitiesOfDiscontinuedOperations
|
1640496 | usd |
CY2023Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
19606010 | usd |
CY2022Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
10127748 | usd |
CY2023Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
163359 | usd |
CY2022Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
700411 | usd |
CY2023Q2 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
895833 | usd |
CY2022Q2 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
3180406 | usd |
CY2023Q2 | upxi |
Notes Payable Related Partie Noncurrent
NotesPayableRelatedPartieNoncurrent
|
7605085 | usd |
CY2022Q2 | upxi |
Notes Payable Related Partie Noncurrent
NotesPayableRelatedPartieNoncurrent
|
0 | usd |
CY2023Q2 | us-gaap |
Notes Payable
NotesPayable
|
7746157 | usd |
CY2022Q2 | us-gaap |
Notes Payable
NotesPayable
|
5695726 | usd |
CY2023Q2 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
16410434 | usd |
CY2022Q2 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
9576543 | usd |
CY2022Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
100000000 | shares |
CY2022Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
500000 | shares |
CY2022Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
500000 | shares |
CY2023Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
500 | usd |
CY2022Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
500 | usd |
CY2022Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
20215961 | shares |
CY2022Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
16713345 | shares |
CY2023Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
20216 | usd |
CY2022Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
16713 | usd |
CY2023Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
51522229 | usd |
CY2022Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
34985597 | usd |
CY2023Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-23201175 | usd |
CY2022Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-6270886 | usd |
CY2023Q2 | upxi |
Stockholders Equity Attribute To Parent
StockholdersEquityAttributeToParent
|
28341770 | usd |
CY2022Q2 | upxi |
Stockholders Equity Attribute To Parent
StockholdersEquityAttributeToParent
|
28731924 | usd |
CY2023Q2 | us-gaap |
Minority Interest
MinorityInterest
|
-505147 | usd |
CY2022Q2 | us-gaap |
Minority Interest
MinorityInterest
|
54820 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
27836623 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
28786744 | usd |
CY2023Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
63853067 | usd |
CY2022Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
48491035 | usd |
CY2023 | us-gaap |
Revenues
Revenues
|
80676509 | usd |
CY2022 | us-gaap |
Revenues
Revenues
|
23065344 | usd |
CY2023 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
47118189 | usd |
CY2022 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
8195735 | usd |
CY2023 | us-gaap |
Gross Profit
GrossProfit
|
33558320 | usd |
CY2022 | us-gaap |
Gross Profit
GrossProfit
|
14869609 | usd |
CY2023 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
10376003 | usd |
CY2022 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
5116868 | usd |
CY2023 | us-gaap |
Production And Distribution Costs
ProductionAndDistributionCosts
|
12369903 | usd |
CY2022 | us-gaap |
Production And Distribution Costs
ProductionAndDistributionCosts
|
2214322 | usd |
CY2023 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
9546188 | usd |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
9141667 | usd |
CY2023 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3664538 | usd |
CY2022 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3331586 | usd |
CY2023 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
4208991 | usd |
CY2022 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
979988 | usd |
CY2023 | us-gaap |
Depreciation
Depreciation
|
944704 | usd |
CY2022 | us-gaap |
Depreciation
Depreciation
|
574309 | usd |
CY2023 | us-gaap |
Operating Expenses
OperatingExpenses
|
41110327 | usd |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
21358740 | usd |
CY2023 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-7552007 | usd |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-6489131 | usd |
CY2023 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
-4761903 | usd |
CY2022 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
-202120 | usd |
CY2023 | upxi |
Change In Derivative Liability
ChangeInDerivativeLiability
|
1770 | usd |
CY2022 | upxi |
Change In Derivative Liability
ChangeInDerivativeLiability
|
-3293 | usd |
CY2023 | upxi |
Gain On Sale Of Infusionz And Select Assets
GainOnSaleOfInfusionzAndSelectAssets
|
-2212542 | usd |
CY2022 | upxi |
Gain On Sale Of Infusionz And Select Assets
GainOnSaleOfInfusionzAndSelectAssets
|
0 | usd |
CY2023 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
-3746301 | usd |
CY2022 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | usd |
CY2023 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
0 | usd |
CY2022 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
5500 | usd |
CY2023 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-200512 | usd |
CY2022 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
0 | usd |
CY2023 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
0 | usd |
CY2022 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
300995 | usd |
CY2023 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-10919488 | usd |
CY2022 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
101082 | usd |
CY2023 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-18471495 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-6388049 | usd |
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
3049293 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
518398 | usd |
CY2023 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-15422202 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-5869651 | usd |
CY2023 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
|
-1729636 | usd |
CY2022 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
|
-1160160 | usd |
CY2023 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
-338418 | |
CY2022 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
4983781 | |
CY2023 | us-gaap |
Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
|
559967 | usd |
CY2022 | us-gaap |
Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
|
-54820 | usd |
CY2023 | us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
-16930289 | usd |
CY2022 | us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
-2100850 | usd |
CY2023 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-0.86 | |
CY2022 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-0.36 | |
CY2023 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
-0.10 | |
CY2022 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
-0.07 | |
CY2023 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.96 | |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.43 | |
CY2023 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
-0.86 | |
CY2022 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
-0.36 | |
CY2023 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.96 | |
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.43 | |
CY2023 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
17877959 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
16224520 | shares |
CY2023 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
17877959 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
16224520 | shares |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
21217973 | usd |
CY2022 | upxi |
Issuance Of Common Stock For Acquisition Amount
IssuanceOfCommonStockForAcquisitionAmount
|
7946815 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
2755016 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
717474 | usd |
CY2022 | upxi |
Warrant Issued Related To Debt
WarrantIssuedRelatedToDebt
|
171384 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2046030 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
28786744 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
28786744 | usd |
CY2023 | upxi |
Amortization Of Common Stock Issuance For Services
AmortizationOfCommonStockIssuanceForServices
|
140700 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
3664538 | usd |
CY2023 | upxi |
Issuance Of Common Stock For Acquisition Of E Core Amount
IssuanceOfCommonStockForAcquisitionOfECoreAmount
|
6000000 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
607004 | usd |
CY2023 | upxi |
Stock Issued During Period Value New Issue Amount
StockIssuedDuringPeriodValueNewIssueAmount
|
6127893 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-17490256 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
27836623 | usd |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
-16930289 | usd |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-2100850 | usd |
CY2023 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
5153695 | usd |
CY2022 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
2733455 | usd |
CY2023 | upxi |
Non Cash Loss On The Sale Of Infusionz And Select Assets Net
NonCashLossOnTheSaleOfInfusionzAndSelectAssetsNet
|
2212542 | usd |
CY2022 | upxi |
Non Cash Loss On The Sale Of Infusionz And Select Assets Net
NonCashLossOnTheSaleOfInfusionzAndSelectAssetsNet
|
0 | usd |
CY2023 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
0 | usd |
CY2022 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
300995 | usd |
CY2023 | us-gaap |
Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
|
0 | usd |
CY2022 | us-gaap |
Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
|
-5500 | usd |
CY2023 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
118990 | usd |
CY2022 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
1044607 | usd |
CY2023 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
0 | usd |
CY2022 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
131968 | usd |
CY2023 | upxi |
Amortization Of Consideration Discount
AmortizationOfConsiderationDiscount
|
969098 | usd |
CY2022 | upxi |
Amortization Of Consideration Discount
AmortizationOfConsiderationDiscount
|
0 | usd |
CY2023 | upxi |
Amortization Of Senior Security Original Issue Discount
AmortizationOfSeniorSecurityOriginalIssueDiscount
|
62408 | usd |
CY2022 | upxi |
Amortization Of Senior Security Original Issue Discount
AmortizationOfSeniorSecurityOriginalIssueDiscount
|
0 | usd |
CY2023 | us-gaap |
Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
|
3746301 | usd |
CY2022 | us-gaap |
Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
|
0 | usd |
CY2023 | upxi |
Noncontrolling Interest
NoncontrollingInterest
|
-559967 | usd |
CY2022 | upxi |
Noncontrolling Interest
NoncontrollingInterest
|
54820 | usd |
CY2023 | upxi |
Change In Deferred Tax Asset
ChangeInDeferredTaxAsset
|
-3139227 | usd |
CY2022 | upxi |
Change In Deferred Tax Asset
ChangeInDeferredTaxAsset
|
-1061238 | usd |
CY2023 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
0 | usd |
CY2022 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
576774 | usd |
CY2023 | upxi |
Shares Issued For Finder Fee
SharesIssuedForFinderFee
|
1770 | usd |
CY2022 | upxi |
Shares Issued For Finder Fee
SharesIssuedForFinderFee
|
0 | usd |
CY2023 | upxi |
Stock Issued During Period Value Share Based Compensation Total
StockIssuedDuringPeriodValueShareBasedCompensationTotal
|
3664538 | usd |
CY2022 | upxi |
Stock Issued During Period Value Share Based Compensation Total
StockIssuedDuringPeriodValueShareBasedCompensationTotal
|
2755016 | usd |
CY2023 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
476256 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
284998 | usd |
CY2023 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
1260479 | usd |
CY2022 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-2795486 | usd |
CY2023 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
168499 | usd |
CY2022 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
284653 | usd |
CY2023 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
132555 | usd |
CY2022 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
37922 | usd |
CY2023 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
3180049 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-446609 | usd |
CY2023 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
0 | usd |
CY2022 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-478385 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
517697 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
715150 | usd |
CY2023 | us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
-315021 | usd |
CY2022 | us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
-895981 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
202676 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-180831 | usd |
CY2023 | upxi |
Payment To Acquire Lucky Tail
PaymentToAcquireLuckyTail
|
-3528239 | usd |
CY2022 | upxi |
Payment To Acquire Lucky Tail
PaymentToAcquireLuckyTail
|
0 | usd |
CY2023 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
-500000 | usd |
CY2022 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
-2574589 | usd |
CY2023 | upxi |
Acquisition Of New England Technology Inc
AcquisitionOfNewEnglandTechnologyInc
|
-2051587 | usd |
CY2022 | upxi |
Acquisition Of New England Technology Inc
AcquisitionOfNewEnglandTechnologyInc
|
0 | usd |
CY2023 | us-gaap |
Acquisition Costs
AcquisitionCosts
|
1050000 | usd |
CY2022 | us-gaap |
Acquisition Costs
AcquisitionCosts
|
1028763 | usd |
CY2023 | upxi |
Acquisition Of Interative Offers Net Of Cash Acquired
AcquisitionOfInterativeOffersNetOfCashAcquired
|
0 | usd |
CY2022 | upxi |
Acquisition Of Interative Offers Net Of Cash Acquired
AcquisitionOfInterativeOffersNetOfCashAcquired
|
-1854193 | usd |
CY2023 | upxi |
Proceeds From The Sale Of Infusionz And Selected Assets
ProceedsFromTheSaleOfInfusionzAndSelectedAssets
|
5492532 | usd |
CY2023 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
937564 | usd |
CY2022 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
5451773 | usd |
CY2023 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
6000 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-2574858 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-10903318 | usd |
CY2023 | us-gaap |
Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
|
0 | usd |
CY2022 | us-gaap |
Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
|
0 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-2574858 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-10903318 | usd |
CY2023 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
445670 | usd |
CY2022 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
1002874 | usd |
CY2023 | upxi |
Repayments Of Notes Payable Sba
RepaymentsOfNotesPayableSBA
|
-305482 | usd |
CY2022 | upxi |
Repayments Of Notes Payable Sba
RepaymentsOfNotesPayableSBA
|
0 | usd |
CY2023 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
6305406 | usd |
CY2022 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
0 | usd |
CY2023 | upxi |
Proceeds On Note Payable On Building
ProceedsOnNotePayableOnBuilding
|
0 | usd |
CY2022 | upxi |
Proceeds On Note Payable On Building
ProceedsOnNotePayableOnBuilding
|
6678506 | usd |
CY2023 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
6318234 | usd |
CY2022 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
0 | usd |
CY2023 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
3000000 | usd |
CY2022 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
0 | usd |
CY2023 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
6127893 | usd |
CY2023 | upxi |
Proceeds From Stock Repurchase Program
ProceedsFromStockRepurchaseProgram
|
0 | usd |
CY2022 | upxi |
Proceeds From Stock Repurchase Program
ProceedsFromStockRepurchaseProgram
|
-1975888 | usd |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
|
158434 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
|
0 | shares |
CY2023 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
2650000 | usd |
CY2023 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
1470000 | usd |
CY2022 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
0 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
-285333 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
3699744 | usd |
CY2023 | us-gaap |
Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
|
0 | usd |
CY2022 | us-gaap |
Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
|
0 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-285333 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
3699744 | usd |
CY2023 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-2342494 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-6488424 | usd |
CY2023 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
|
-315021 | usd |
CY2022 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
|
-895981 | usd |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
7149806 | usd |
CY2021Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
14534211 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
4492291 | usd |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
7149806 | usd |
CY2023 | us-gaap |
Interest Paid Net
InterestPaidNet
|
2278292 | usd |
CY2022 | us-gaap |
Interest Paid Net
InterestPaidNet
|
64460 | usd |
CY2023 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | usd |
CY2022 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
656000 | usd |
CY2023 | upxi |
Issuance Of Common Stock For Acquisition Of Vitamedica
IssuanceOfCommonStockForAcquisitionOfVitamedica
|
0 | usd |
CY2022 | upxi |
Issuance Of Common Stock For Acquisition Of Vitamedica
IssuanceOfCommonStockForAcquisitionOfVitamedica
|
1764876 | usd |
CY2023 | upxi |
Issuance Of Debt For Acquisition Of Vitamedica
IssuanceOfDebtForAcquisitionOfVitamedica
|
0 | usd |
CY2022 | upxi |
Issuance Of Debt For Acquisition Of Vitamedica
IssuanceOfDebtForAcquisitionOfVitamedica
|
482000 | usd |
CY2023 | upxi |
Issuance Of Common Stock For Acquisition Of E Core
IssuanceOfCommonStockForAcquisitionOfECore
|
0 | usd |
CY2022 | upxi |
Issuance Of Common Stock For Acquisition Of E Core
IssuanceOfCommonStockForAcquisitionOfECore
|
1000000 | usd |
CY2023 | upxi |
Liabilities Assumed From Acquisition Of Vitamedica
LiabilitiesAssumedFromAcquisitionOfVitamedica
|
0 | usd |
CY2022 | upxi |
Liabilities Assumed From Acquisition Of Vitamedica
LiabilitiesAssumedFromAcquisitionOfVitamedica
|
-309574 | usd |
CY2023 | us-gaap |
Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
|
607004 | shares |
CY2022 | us-gaap |
Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
|
0 | shares |
CY2023 | upxi |
Issuance Of Commons Stock For Services
IssuanceOfCommonsStockForServices
|
140700 | usd |
CY2022 | upxi |
Issuance Of Commons Stock For Services
IssuanceOfCommonsStockForServices
|
140700 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
6000000 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
0 | usd |
CY2023 | upxi |
Liabilities Assumed From Acquisition Of E Core
LiabilitiesAssumedFromAcquisitionOfECore
|
-7712168 | usd |
CY2022 | upxi |
Liabilities Assumed From Acquisition Of E Core
LiabilitiesAssumedFromAcquisitionOfECore
|
0 | usd |
CY2023 | upxi |
Operating Assets Designated As Held For Sale
OperatingAssetsDesignatedAsHeldForSale
|
1026043 | usd |
CY2022 | upxi |
Operating Assets Designated As Held For Sale
OperatingAssetsDesignatedAsHeldForSale
|
10790984 | usd |
CY2023 | upxi |
Liabilities Assumed To Acquisition Of Vitamedica
LiabilitiesAssumedToAcquisitionOfVitamedica
|
0 | usd |
CY2022 | upxi |
Liabilities Assumed To Acquisition Of Vitamedica
LiabilitiesAssumedToAcquisitionOfVitamedica
|
-309574 | usd |
CY2023 | upxi |
Issuance Of Stock For Acquisition Of Interactive
IssuanceOfStockForAcquisitionOfInteractive
|
0 | usd |
CY2022 | upxi |
Issuance Of Stock For Acquisition Of Interactive
IssuanceOfStockForAcquisitionOfInteractive
|
2733628 | usd |
CY2023 | upxi |
Liabilities Assumed From Acquisition Of Cygnet
LiabilitiesAssumedFromAcquisitionOfCygnet
|
0 | usd |
CY2022 | upxi |
Liabilities Assumed From Acquisition Of Cygnet
LiabilitiesAssumedFromAcquisitionOfCygnet
|
9472438 | usd |
CY2023 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upexi is a multi-faceted brand owner with established brands in the health, wellness, pet, beauty and other growing markets. We operate in emerging industries with high growth trends and look to drive organic growth of our current brands. We focus on direct to consumer and Amazon brands that are scalable and have anticipated, high industry growth trends. Our goal is to continue to accumulate consumer data and build out a significant customer database across all industries we sell into. The growth of our current customer database has been key to the year-over-year gains in sales and profits. To drive additional growth, we have and will continue to acquire profitable Amazon and eCommerce businesses that can scale quickly and reduce costs through corporate synergies. We utilize our in-house, SaaS programmatic ad technology to help achieve a lower cost per acquisition and accumulate consumer data for increased cross-selling between our growing portfolio of brands.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company primarily conducts its business operations through the following subsidiaries: Upexi, Inc. (the “Company”) is a Nevada corporation with fourteen active subsidiaries, including thirteen wholly owned subsidiaries and one subsidiary, Cygnet Online, LLC, a Delaware limited liability company, that is 55% owned. The Company’s fourteen active subsidiaries are as follows: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">☐</p></td><td colspan="3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">HAVZ, LLC, d/b/a/ Steam Wholesale, a California limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">o</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">SWCH, LLC, a Delaware limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">o</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cresco Management, LLC, a California limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">☐ </p></td><td colspan="3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Trunano Labs, Inc., a Nevada corporation</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">☐</p></td><td colspan="3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">MW Products, Inc., a Nevada corporation</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">☐</p></td><td colspan="3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upexi Holding, LLC, a Delaware limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">o</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upexi Pet Products, LLC, a Delaware limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">☐</p></td><td colspan="3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">VitaMedica, Inc, a Nevada corporation</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">☐</p></td><td colspan="3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upexi Enterprise, LLC, a Delaware limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">o</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upexi Property & Assets, LLC, a Delaware limited liability company</p></td></tr><tr style="height:15px"><td style="width:3%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:3%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:3%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:3%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">■</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upexi 17129 Florida, LLC, a Delaware limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">o</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">E-Core Technology, Inc.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">o</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upexi Distribution Management LLC, a Delaware limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">☐</p></td><td colspan="3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Interactive Offers, LLC (“Interactive”), a Delaware limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">☐</p></td><td colspan="3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cygnet Online, LLC (“Cygnet”), a Delaware limited liability company, 55% owned.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In addition, the Company has four wholly owned subsidiaries that had no activity during the year ended June 30, 2023 or for the year ended June 30, 2022. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Steam Distribution, LLC, a California limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">One Hit Wonder, Inc., a California corporation</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">One Hit Wonder Holdings, LLC, a California limited liability company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Vape Estate, Inc., a Nevada Corporation</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Our products are distributed in the United States of America and internationally through multiple entities and managed through our locations in Florida, California, and Nevada.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Upexi</strong> operates from our corporate location in Tampa, Florida where direct to consumer and Amazon sales are driven by on-site and remote teams for all brands. The Tampa location also supports all the other locations with accounting, corporate oversight, day-to-day finances, business development and operational management operating from this location.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>VitaMedica</strong> operates mainly from our California location with product development and day to day management with the primary fulfillment center located in Tampa Florida. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Interactive Offers</strong> is operated from its Florida office with day-to-day operations supported by various off site remote positions, and majority of the development team operating through out of Portugal.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Cygnet Online</strong> operates from our South Florida location with a full on-site GMP warehouse and distribution center, day-to-day operations of our Amazon liquidation business team from this location with support of remote team members.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Lucky Tail</strong> operates from our Clearwater, Florida location with sales and marketing driven by on-site and remote teams that operate the Amazon sales strategy and daily business operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>HAVZ, LLC, d/b/a/ Steam</strong> <strong>Wholesale</strong> operates manufacturing and/or distribution centers in Henderson, Nevada supporting our health and wellness products, including those products manufactured with hemp ingredients and our overall distribution operations. We have continued to manage these operations with corporate focus on larger opportunities that have warranted the majority of corporate focus and investments for the future.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Business Acquisitions</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On August 1, 2021, the Company completed an asset purchase agreement with Grove Acquisition Subsidiary, Inc., a Nevada corporation and wholly owned subsidiary of the Company, and the members of VitaMedica Corporation, a California corporation, to purchase all the assets and assume certain liabilities of VitaMedica. VitaMedica is a leading online seller of supplements for surgery, recovery, skin, beauty, health, and wellness.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 1, 2021, the Company entered into an equity interest purchase agreement with Gyprock Holdings LLC, a Delaware limited liability company, MFA Holdings Corp., a Florida corporation, and Sherwood Ventures, LLC, a Texas limited liability company, to acquire all the outstanding membership interest of Interactive Offers, LLC, a Delaware limited liability company. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On April 1, 2022, the Company entered into a securities purchase agreement with the single investor to purchase 55% of the equity interest in Cygnet Online, LLC, a Delaware limited liability company, and agreements to enable the Company to purchase the remaining 45% over the following two years. On September 1, 2023 the Company purchased the remaining 45% of Cygnet Online, LLC for $500,000 cash, 90,909 shares of the Company’s common stock and a $300,000 cash payment due on September 1, 2024. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On August 12, 2022, the Company completed an asset purchase agreement with GA Solutions, LLC, a Delaware limited liability company (“LuckyTail”), pursuant to which the Company acquired substantially all assets of LuckyTail. LuckyTail sells pet nail grinders and other pet products through various sales channels including some international sales channels. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 31, 2022, the Company and its wholly owned subsidiary Upexi Enterprise, LLC, completed a securities purchase agreement to purchase the outstanding stock of E-Core Technology, Inc. d/b/a New England Technology, Inc. (“E-Core”), a Florida corporation. E-Core distributes non-owned branded products to national retail distributors and has branded products in the toy industry that E-Core sells direct to consumers through online sales channels and to national retail distributors. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Business Divested</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 26, 2022, the Company executed a membership interest purchase agreement to sell 100% of the membership interests of Infusionz LLC, a Colorado limited liability company (“Infusionz”), included in the sale was all rights to Infusionz brands and the manufacturing of certain private label business. Infusionz was originally purchased by the Company in July of 2020. The divestiture of Infusionz and related private label manufacturing represents a strategic shift in our operations and will allow us to become a predominantly product distribution focused company for both our Company owned brands and non-owned brands. Accordingly, the results of the business were classified as discontinued operations in our condensed statements of operations and excluded from both continuing operations and segment results for all periods presented.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On August 31, 2023, Upexi, Inc. (the “Company”) entered into an Equity Interest Purchase Agreement (“EIPA”) pursuant to which the Company sold one hundred percent (100%) of the issued and outstanding equity (the “Interests”) of its wholly owned subsidiary Interactive Offers, LLC (“Interactive”) to Amplifyir Inc. (the “Buyer”). The purchase price for the Interests was One Million Two Hundred Fifty Thousand Dollars ($1,250,000), subject to certain customary post-closing adjustments. In addition, the Buyer is obligated to pay the Company two-and one- half percent (2.5%) of certain advertising revenues of Interactive for a two-year period post-closing. Accordingly, the results of the business were classified as discontinued operations in our statements of operations and excluded from both continuing operations and segment results for all periods presented.</p> | |
CY2022Q2 | us-gaap |
Investments And Cash
InvestmentsAndCash
|
300000 | usd |
CY2023Q3 | us-gaap |
Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
|
1250000 | usd |
CY2023Q3 | upxi |
Obligated To Pay
ObligatedToPay
|
0.025 | pure |
CY2023 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">Use of Estimates</span></strong> <strong>-</strong> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Significant estimates underlying the Company’s reported financial position and results of operations include the allowance for doubtful accounts, useful lives of property and equipment, impairment of long-lived assets, inventory valuation, fair value of stock-based compensation and valuation allowance on deferred tax assets.</p> | |
CY2023 | upxi |
Allowance For Doubtful Accounts Receivables Current
AllowanceForDoubtfulAccountsReceivablesCurrent
|
65500 | usd |
CY2022 | upxi |
Allowance For Doubtful Accounts Receivables Current
AllowanceForDoubtfulAccountsReceivablesCurrent
|
57000 | usd |
CY2023 | upxi |
Bad Debt Expense
BadDebtExpense
|
131968 | usd |
CY2023 | upxi |
Finished Goods Inventory
FinishedGoodsInventory
|
11557128 | usd |
CY2022 | upxi |
Finished Goods Inventory
FinishedGoodsInventory
|
4725685 | usd |
CY2023 | upxi |
Inventory Reserve
InventoryReserve
|
475000 | usd |
CY2022 | upxi |
Inventory Reserve
InventoryReserve
|
50000 | usd |
CY2023Q2 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
0 | usd |
CY2023Q2 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
616893 | usd |
CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
34091 | usd |
CY2023Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
582802 | usd |
CY2023 | upxi |
Lease Term1
LeaseTerm1
|
P5Y | |
CY2023Q2 | us-gaap |
Goodwill Gross
GoodwillGross
|
2889158 | usd |
CY2023 | us-gaap |
Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
|
857143 | usd |
CY2023Q2 | us-gaap |
Intangible Assets Current
IntangibleAssetsCurrent
|
716944 | usd |
CY2023 | us-gaap |
Revenue Recognition Leases
RevenueRecognitionLeases
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">Revenue Recognition</span></strong> <strong>-</strong> The Company analyzes its contracts and purchase orders to assess whether revenue is properly recognized. In determining the appropriate amount of revenue to be recognized as the Company fulfills its obligations under each of its agreements, whether for goods and services or licensing, the Company performs the following steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations based on estimated selling prices; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company acts as principal in its revenue transactions as the Company is the primary obligor in the transactions. Generally, the Company recognizes revenue for its products when ownership is transferred to the customer, provided no significant obligations remain and collection is probable.</p> | |
CY2023 | us-gaap |
Revenue Recognition Revenue Reductions
RevenueRecognitionRevenueReductions
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">Product Revenue</span></strong><em> - </em>Most of the Company’s revenue contracts are from domestic sales and represent a single performance obligation related to the fulfillment of customer orders for the purchase of its products. Net sales reflect the transaction prices for these contracts based on the Company’s selling list price, which is then reduced by estimated costs for trade promotional programs, consumer incentives, and allowances and discounts used to incentivize sales growth and build brand awareness.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company recognizes revenue at the point in time that control of the ordered product is transferred to the customer, which is upon shipment to the customer or other customer-designated delivery point. Taxes collected from customers that are remitted to governmental agencies are accounted for on a net basis and not included as revenue.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company does not accept sales returns from wholesale customers, as the products are pre-approved prior to production and shipment. E-Commerce product returns must be completed within 45 days of the date of purchase. The Company does not accrue estimated sales returns as historical sales returns have been minimal. The Company records deferred revenues when cash payments are received or due in advance of performance, including amounts which are refundable. Substantially all the deferred revenue as of June 30, 2022, was recognized as revenue in the year ended June 30, 2023.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Shipping and handling fees billed to customers are included in revenue, as this revenue is not directly related to the distribution costs associated with an order. Shipping fees associated with freight are generally included in distribution costs.</p> | |
CY2023 | us-gaap |
Advertising Expense
AdvertisingExpense
|
7978607 | usd |
CY2022 | us-gaap |
Advertising Expense
AdvertisingExpense
|
3225256 | usd |
CY2023 | upxi |
Non Employee Stock Based Paymentspolicytextblock
NonEmployeeStockBasedPaymentspolicytextblock
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">Non-employee Stock-based Payments</span></strong> <strong>-</strong> The Company’s accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services follows the provisions of ASC 2018-07, which simplifies the accounting for non-employee share-based payment transactions. The amendments specify that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. Stock-based payments related to non-employees is accounted for based on the fair value of the related stock or options or the fair value of the services, whichever is more readily determinable. The measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the consultant or vendor is reached or (ii) the date at which the consultant or vendor’s performance is complete. In the case of equity instruments issued to consultants, the fair value of the equity instrument is recognized over the term of the consulting agreement.</p> | |
CY2023 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
4839278 | shares |
CY2022 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
4279888 | shares |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
220297 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
106850 | shares |
CY2023 | us-gaap |
Preferred Stock Dividends Shares
PreferredStockDividendsShares
|
277778 | shares |
CY2022 | us-gaap |
Preferred Stock Dividends Shares
PreferredStockDividendsShares
|
277778 | shares |
CY2023 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
|
1157651 | shares |
CY2022 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
|
0 | shares |
CY2023 | upxi |
Weighted Average Number Of Diluted Shares Outstanding1
WeightedAverageNumberOfDilutedSharesOutstanding1
|
6495004 | shares |
CY2022 | upxi |
Weighted Average Number Of Diluted Shares Outstanding1
WeightedAverageNumberOfDilutedSharesOutstanding1
|
4664516 | shares |
CY2023 | us-gaap |
Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">Deferred Revenue</span></strong><strong> - </strong>The Company records deposits as deferred revenue when a customer pays in advance of shipping the product. Once the product is shipped, the deposit is recorded as revenue and the related commissions are paid. All products were shipped related to deposits in deferred revenue, in less than one year.</p> | |
CY2023Q2 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
441641 | usd |
CY2023 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
72648376 | usd |
CY2022 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
13058736 | usd |
CY2022 | upxi |
Amortization Expense
AmortizationExpense
|
1615500 | usd |
CY2023 | upxi |
Amortization Expense Monthly
AmortizationExpenseMonthly
|
134625 | usd |
CY2023 | upxi |
Amortization Expense
AmortizationExpense
|
534721 | usd |
CY2023 | upxi |
Amortization Expense Annually
AmortizationExpenseAnnually
|
1615500 | usd |
CY2023Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
9455848 | usd |
CY2022Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
8211689 | usd |
CY2023Q2 | us-gaap |
Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
|
1921780 | usd |
CY2022Q2 | us-gaap |
Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
|
872823 | usd |
CY2023Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
7526463 | usd |
CY2022Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
7338866 | usd |
CY2023 | upxi |
Depreciation Expense
DepreciationExpense
|
944704 | usd |
CY2022 | upxi |
Depreciation Expense
DepreciationExpense
|
574309 | usd |
CY2023 | upxi |
Amortization Intangible Assets
AmortizationIntangibleAssets
|
4208991 | usd |
CY2022 | upxi |
Amortization Intangible Assets
AmortizationIntangibleAssets
|
979988 | usd |
CY2023Q2 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
143302 | usd |
CY2023Q2 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
121273 | usd |
CY2023Q2 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
33683 | usd |
CY2023Q2 | us-gaap |
Finite Lived Customer Relationships Gross
FiniteLivedCustomerRelationshipsGross
|
1329000 | usd |
CY2023Q2 | us-gaap |
Finite Lived Trade Names Gross
FiniteLivedTradeNamesGross
|
463000 | usd |
CY2023Q2 | us-gaap |
Finite Lived Noncompete Agreements Gross
FiniteLivedNoncompeteAgreementsGross
|
143000 | usd |
CY2023Q2 | upxi |
Intangible Assets Online Sales Channels
IntangibleAssetsOnlineSalesChannels
|
1800000 | usd |
CY2023Q2 | upxi |
Intangible Assets Vendor Relationships
IntangibleAssetsVendorRelationships
|
6000000 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
9735000 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
4456740 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
3775782 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
3775782 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
1538187 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
25467 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
13571960 | usd |
CY2023Q2 | us-gaap |
Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
|
1307299 | usd |
CY2022Q2 | us-gaap |
Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
|
760900 | usd |
CY2023 | upxi |
Lease Term
LeaseTerm
|
1 year to 5 years | |
CY2023 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
568031 | usd |
CY2023 | upxi |
Additional Lease Expense
AdditionalLeaseExpense
|
117992 | usd |
CY2023Q2 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
318636 | usd |
CY2023Q2 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.050 | pure |
CY2023 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
341644 | usd |
CY2022 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
368680 | usd |
CY2023 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
304827 | usd |
CY2022 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
273746 | usd |
CY2023 | us-gaap |
Interest Expense Other
InterestExpenseOther
|
35003 | usd |
CY2022 | us-gaap |
Interest Expense Other
InterestExpenseOther
|
38290 | usd |
CY2023 | us-gaap |
Lease Cost
LeaseCost
|
681474 | usd |
CY2022 | us-gaap |
Lease Cost
LeaseCost
|
680716 | usd |
CY2023Q2 | us-gaap |
Accrued Royalties Current
AccruedRoyaltiesCurrent
|
0 | usd |
CY2022Q2 | us-gaap |
Accrued Royalties Current
AccruedRoyaltiesCurrent
|
6418 | usd |
CY2023Q2 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
655187 | usd |
CY2022Q2 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
147887 | usd |
CY2023Q2 | upxi |
Accrued Vendor Liabilities
AccruedVendorLiabilities
|
861664 | usd |
CY2022Q2 | upxi |
Accrued Vendor Liabilities
AccruedVendorLiabilities
|
0 | usd |
CY2023Q2 | us-gaap |
Accrued Income Taxes
AccruedIncomeTaxes
|
47070 | usd |
CY2022Q2 | us-gaap |
Accrued Income Taxes
AccruedIncomeTaxes
|
108425 | usd |
CY2023Q2 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
0 | usd |
CY2022Q2 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
81909 | usd |
CY2023Q2 | us-gaap |
Accrued Liabilities For Commissions Expense And Taxes
AccruedLiabilitiesForCommissionsExpenseAndTaxes
|
1360000 | usd |
CY2022Q2 | us-gaap |
Accrued Liabilities For Commissions Expense And Taxes
AccruedLiabilitiesForCommissionsExpenseAndTaxes
|
0 | usd |
CY2022Q2 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
471993 | usd |
CY2023Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3365562 | usd |
CY2022Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
816632 | usd |
CY2023Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
|
9830380 | usd |
CY2023Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
7960764 | usd |
CY2023Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
|
4630403 | usd |
CY2023Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
|
1052943 | usd |
CY2023Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
|
784450 | usd |
CY2023Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
|
3486952 | usd |
CY2023Q2 | us-gaap |
Long Term Debt
LongTermDebt
|
27745892 | usd |
CY2023Q2 | upxi |
Note Original Discount
NoteOriginalDiscount
|
1856653 | usd |
CY2023Q2 | upxi |
Convertible Promissory Notes And Notes Payable
ConvertiblePromissoryNotesAndNotesPayable
|
25889239 | usd |
CY2023Q1 | us-gaap |
Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
|
2150000 | usd |
CY2023Q1 | upxi |
Issuance Of Restricted Stock Shares
IssuanceOfRestrictedStockShares
|
134000 | shares |
CY2023Q1 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
4.53 | |
CY2023Q1 | us-gaap |
Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
|
0.1811 | pure |
CY2023Q1 | us-gaap |
Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
|
5.00 | |
CY2023 | upxi |
Proceeds From Related Party
ProceedsFromRelatedParty
|
600000 | usd |
CY2023Q1 | us-gaap |
Accounts Payable Interest Bearing Interest Rate
AccountsPayableInterestBearingInterestRate
|
0.10 | pure |
CY2023 | upxi |
Common Stock For Prepayment Of Interest On Note Payable Shares
CommonStockForPrepaymentOfInterestOnNotePayableShares
|
134000 | shares |
CY2023 | upxi |
Common Stock For Prepayment Of Interest On Note Payable Value
CommonStockForPrepaymentOfInterestOnNotePayableValue
|
607020 | usd |
CY2023Q2 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
90909 | shares |
CY2023Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
162727 | usd |
CY2022 | us-gaap |
Public Utilities Allowance For Funds Used During Construction Rate
PublicUtilitiesAllowanceForFundsUsedDuringConstructionRate
|
0 | pure |
CY2023 | upxi |
Provision For Income Taxes
ProvisionForIncomeTaxes
|
0.2583 | pure |
CY2022 | upxi |
Provision For Income Taxes
ProvisionForIncomeTaxes
|
0.2037 | pure |
CY2022 | upxi |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDividendRate
|
0 | pure |
CY2023 | upxi |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDividendRate
|
0 | pure |
CY2023 | us-gaap |
Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Term1
ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1
|
P6Y6M | |
CY2022 | us-gaap |
Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Term1
ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1
|
P6Y6M | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.69 | pure |
CY2023 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
349260 | usd |
CY2022 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
80769 | usd |
CY2023 | us-gaap |
Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
|
-3601298 | usd |
CY2022 | us-gaap |
Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
|
-599167 | usd |
CY2023 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-3049293 | usd |
CY2022 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-518398 | usd |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.2100 | pure |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.2100 | pure |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation Deductions Medicare Prescription Drug Benefit
EffectiveIncomeTaxRateReconciliationDeductionsMedicarePrescriptionDrugBenefit
|
0.0504 | pure |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Deductions Medicare Prescription Drug Benefit
EffectiveIncomeTaxRateReconciliationDeductionsMedicarePrescriptionDrugBenefit
|
-0.0270 | pure |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
-0.0024 | pure |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0.0279 | pure |
CY2023 | upxi |
Tax Return To Provision
TaxReturnToProvision
|
-0.0267 | pure |
CY2023 | srt |
Mortgage Loans On Real Estate Interest Rate
MortgageLoansOnRealEstateInterestRate
|
0.0181 | pure |
CY2023 | upxi |
Other Net
OtherNet
|
0.0090 | pure |
CY2022 | upxi |
Other Net
OtherNet
|
0.0072 | pure |
CY2023 | us-gaap |
Public Utilities Allowance For Funds Used During Construction Rate
PublicUtilitiesAllowanceForFundsUsedDuringConstructionRate
|
0 | pure |
CY2023 | us-gaap |
Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
|
752863 | usd |
CY2022 | us-gaap |
Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
|
296352 | usd |
CY2023 | upxi |
Reward Points
RewardPoints
|
0 | usd |
CY2022 | upxi |
Reward Points
RewardPoints
|
1536 | usd |
CY2023 | upxi |
Inventory Write Off
InventoryWriteOff
|
0 | usd |
CY2022 | upxi |
Inventory Write Off
InventoryWriteOff
|
11965 | usd |
CY2023 | us-gaap |
Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
|
1015997 | usd |
CY2022 | upxi |
Amortization Of Intangibles Assets
AmortizationOfIntangiblesAssets
|
691411 | usd |
CY2023 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
1999688 | usd |
CY2022 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
887550 | usd |
CY2023 | us-gaap |
Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
|
56112 | usd |
CY2022 | us-gaap |
Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
|
13760 | usd |
CY2023 | upxi |
Accrued Compensations
AccruedCompensations
|
19323 | usd |
CY2022 | upxi |
Accrued Compensations
AccruedCompensations
|
19970 | usd |
CY2023 | us-gaap |
Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
|
18196 | usd |
CY2022 | us-gaap |
Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
|
80215 | usd |
CY2023 | us-gaap |
Other Income
OtherIncome
|
7 | usd |
CY2022 | us-gaap |
Other Income
OtherIncome
|
0 | usd |
CY2023 | us-gaap |
Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
|
0 | usd |
CY2022 | us-gaap |
Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
|
0 | usd |
CY2023 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
5604056 | usd |
CY2022 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
2002759 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
|
3097791 | usd |
CY2022Q2 | us-gaap |
Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
|
1411198 | usd |
CY2022Q2 | upxi |
Federal Net Operating Loss
FederalNetOperatingLoss
|
2506514 | usd |
CY2023 | upxi |
Scheduleofinventory Or Working Capital Tabletextblock
ScheduleofinventoryOrWorkingCapitalTabletextblock
|
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Tangible assets, inventory / working capital*</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,344,000 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Tangible assets, warehouse and manufacturing equipment, net of accumulated depreciation*</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(679,327 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Goodwill</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,413,814 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Intangible assets, net of accumulated amortization</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(946,996 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued and incurred expenses related to the transaction and additional working capital*</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,051,500 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Consideration received, including cash, debt and equity, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">15,000,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total gain recognized</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">7,564,363</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> |